| Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723) |
|---|
| 10/23/1997 | WO1997038703A1 Chimeric isoprenoid synthases and uses thereof |
| 10/21/1997 | US5679641 Peptides of human P53 protein for use in human T cell response inducing compositions, and human P53 protein-specific cytotoxic t-lymphocytes |
| 10/16/1997 | WO1997037995A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines |
| 10/16/1997 | CA2251072A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines |
| 10/08/1997 | EP0777679A4 Delivery of nucleic acids |
| 09/25/1997 | WO1997035009A1 Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides |
| 09/12/1997 | WO1997033174A1 Selectively n-alkylated peptidomimetic combinatorial libraries and compounds therein |
| 09/12/1997 | CA2248078A1 Selectively n-alkylated peptidomimetic combinatorial libraries and compounds therein |
| 09/09/1997 | US5665876 Acylation, amidation |
| 09/03/1997 | CN1158619A Delivery of nucleic acids |
| 09/02/1997 | US5662911 Benzodiazepine protein conjugates |
| 08/13/1997 | EP0789031A2 Acellular vaccine |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/15/1997 | US5648455 Treatment of drug resistant bacteria |
| 07/15/1997 | CA2063400C Inhibition of the n-end rule pathway in living cells |
| 06/25/1997 | CN1152615A Process for preparing piptide acylate from protein of silk filature pupa by biological degradation |
| 06/19/1997 | WO1997021431A1 Cobalt schiff base compounds |
| 06/19/1997 | CA2240183A1 Cobalt schiff base compounds |
| 06/18/1997 | EP0610330B1 Monoclonal antibodies directed against the microtubule-associated protein tau |
| 06/18/1997 | CN1152315A Monocyte chemotactic protein-4 |
| 06/11/1997 | EP0777679A1 Delivery of nucleic acids |
| 06/04/1997 | EP0776359A1 Regulated apoptosis |
| 05/29/1997 | WO1997019194A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE |
| 05/29/1997 | CA2238290A1 Methods for determining compounds capable of inhibiting the activities of the ha-ras oncogene |
| 05/27/1997 | US5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/20/1997 | US5631151 Melanin production by transformed organisms |
| 05/09/1997 | WO1997016542A1 Diagnostics and treatments of periodontal disease |
| 04/23/1997 | EP0707599B1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 04/08/1997 | US5618927 Incubation in solution of tris |
| 03/27/1997 | WO1997011090A1 Inhibition of tumor growth |
| 03/27/1997 | WO1997010828A1 Therapy for tissue membrane insufficiency |
| 03/25/1997 | US5614499 Anticoagulants; treatment or prophylaxis of thrombosis |
| 03/12/1997 | EP0761683A1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor |
| 03/05/1997 | EP0512087B1 Process for reactivating denatured protein |
| 03/04/1997 | US5607841 Preparation and proteolytic degradation of a macromolecular protein complex from fibrinogen |
| 02/27/1997 | WO1997007232A1 Antigenic preparations |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/11/1997 | US5602253 Peptides derivatives |
| 02/05/1997 | CN1033976C Preparation of polypeptides used as blockers of calcium channels |
| 01/07/1997 | US5591851 Antiviral compounds |
| 01/03/1997 | CA2361012A1 Conformationally-restricted combinatorial library composition and method |
| 11/27/1996 | CN1136779A Long-acting injection suspensions and process for their preparation |
| 11/05/1996 | US5571713 Therapeutic treatment for inhibiting vascular restenosis |
| 10/23/1996 | CN1134109A Chemically-defined non-polymeric valency plateform molecules and conjugates thereof |
| 10/10/1996 | WO1996031220A1 Cyclodextrin compounds and methods of making and use thereof |
| 10/10/1996 | CA2217305A1 Cyclodextrin compounds and methods of making and use thereof |
| 10/09/1996 | EP0736102A1 Method for preparing peptide products, and resulting products |
| 10/03/1996 | WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 09/25/1996 | EP0733664A2 Polymers of aspartic acid with sequestering activity, process for their preparation and use thereof |
| 09/25/1996 | EP0732934A1 Long-acting injection suspensions and a process for their preparation |
| 09/24/1996 | CA2026418C Polypeptides useful as blockers of calcium channels |
| 09/04/1996 | CN1130401A Regulated apoptosis |
| 09/03/1996 | US5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 09/03/1996 | US5552161 Low viscosity, highly concentrated surfactant suspension |
| 08/14/1996 | EP0726275A1 Benzodiazepine protein conjugates and their use in benzodiazepine immunoassays |
| 07/24/1996 | EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/17/1996 | CN1126761A DNA sequences encoding novel biosynthetic insulin precursors and process for preparation of insulin |
| 07/03/1996 | EP0719274A1 Method for dosing therapeutic compounds |
| 07/03/1996 | EP0719273A1 Nucleotide analogs |
| 07/03/1996 | EP0673653A4 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it. |
| 07/03/1996 | EP0673652A4 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it. |
| 07/02/1996 | US5531185 Manufacturing apparatus for use in a micro-gravity environment |
| 04/24/1996 | EP0707599A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/03/1996 | EP0704527A2 DNA sequences encoding biosynthetic insulin precursors and process for prepation of insulin |
| 03/27/1996 | EP0702689A1 Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids |
| 03/20/1996 | EP0701568A1 New peptide derivatives |
| 02/22/1996 | WO1996005218A1 Delivery of nucleic acids |
| 02/21/1996 | EP0697023A1 3-(aminoacyl-amino)-saccharides and method for preparing them |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/06/1996 | CA2155451A1 Dna sequences encoding novel biosynthetic insulin precursors and process for preparation of insulin |
| 01/10/1996 | EP0637970A4 Polyamino acid superabsorbents. |
| 12/13/1995 | EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
| 12/06/1995 | EP0429542B1 Leukocyte adhesion inhibitor |
| 11/30/1995 | WO1995032219A1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor |
| 11/28/1995 | US5470953 Human β2 integrin α subunit |
| 09/27/1995 | EP0673653A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 09/27/1995 | EP0673652A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 09/20/1995 | EP0672142A1 Multivalent and multispecific binding proteins, their manufacture and use |
| 08/23/1995 | EP0668358A1 Antibiotic WAP-8294A, method for preparing the same and antibacterial composition |
| 08/15/1995 | CA1336739C Diphosphonate-derivatized macromolecules |
| 08/02/1995 | CN1106020A Synthetic method of casein iodide |
| 06/29/1995 | WO1995017518A1 Method for preparing peptide products, and resulting products |
| 06/29/1995 | WO1995017412A1 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT |
| 06/29/1995 | CA2179738A1 Method for preparing peptide products, and resulting products |
| 06/29/1995 | CA2156622A1 Novel human .beta.2 integrin alpha subunit |
| 06/15/1995 | WO1995015767A1 Long-acting injection suspensions and a process for their preparation |
| 04/05/1995 | EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
| 04/05/1995 | EP0646017A1 Immune suppressive product |
| 03/29/1995 | EP0644930A1 Monoclonal antibody against the extra-villous trophoblast |
| 03/23/1995 | WO1995007920A1 Nucleotide analogs |
| 03/23/1995 | WO1995007919A1 Method for dosing therapeutic compounds |
| 03/23/1995 | CA2171868A1 Method for dosing therapeutic compounds |
| 03/22/1995 | EP0643726A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 03/16/1995 | WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 02/15/1995 | EP0637970A1 Polyamino acid superabsorbents |
| 01/11/1995 | EP0632813A1 Amadori reaction compounds and products, process for their manufacture, and their use |
| 01/05/1995 | WO1995000555A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 01/04/1995 | EP0632054A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |